Micro-SPECT Imaging of Acute Ischemic Stroke with Radioiodinated Riboflavin in Rat MCAO Models via Riboflavin Transporter Targeting
Micro-SPECT Imaging of Acute Ischemic Stroke with Radioiodinated Riboflavin in Rat MCAO Models via Riboflavin Transporter Targeting
复制标题
通过核黄素转运蛋白靶向,在大鼠 MCAO 模型中使用放射性碘化核黄素对急性缺血性中风进行显微 SPECT 成像。
DOI:
10.1021/acschemneuro.2c00177
复制
发表时间:
2022-06-26
影响因子:
5
通讯作者:
Zhang, Xianzhong
中科院分区:
文献类型:
--
作者:
Li, Jindian;Chen, Yingxi;Zhang, Xianzhong
Riboflavin transporter-3 (RFVT3) is a recently discovered and novel biomarker for the theranostics of nervous system diseases. RFVT3 is significantly overexpressed in cerebral injury after ischemic stroke. Herein, we first reported an RFVT3-targeted tracer I-131-riboflavin (I-131-RFLA) for SPECT imaging of ischemic stroke in vivo. I-131-RFLA was radiosynthesized by the iodogen-coating method. I-131-RFLA possessed a radiochemical yield of 69.2 +/- 3.7% and greater than 95% radiochemical purity. The representative SPECT/CT images using I-131-RFLA demonstrated the conspicuously increased tracer uptake in the cerebral injury by comparison with the contralateral normal brain at 1 h and 3 and 7 d after stroke. Ex vivo autoradiography demonstrated that the ratio of infarcted to normal brain uptake was 3.63 and it was decreased to 1.98 after blocking, which reconfirmed the results of SPECT images. Importantly, a significant correlation was identified between RFVT3 expression and brain injury by H&E and immunohistochemistry staining. Therefore, RFVT3 is a new and potential biomarker for the early diagnosis of ischemic stroke. In addition, I-131-RFLA is a promising SPECT tracer for imaging RFVT3-related ischemic cerebral injury in vivo.